Healthcare Services

A key trend shaping the Female Infertility Market involves the Technological Advancements In Market With Non-Invasive Diagnostic Tests

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Female Infertility Market Over The Period 2026–2030?

The market for female infertility has shown consistent expansion over recent years. This market is projected to expand from $1.86 billion in 2025 to reach $1.94 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.1%. Historically, this growth can be ascribed to several factors, including trends towards delayed childbearing, a heightened awareness of infertility issues, the availability of various fertility drugs, an increase in reproductive health clinics, and advancements in diagnostic imaging techniques.

The female infertility market size is set to experience steady expansion in the coming years, with projections indicating a rise to $2.26 billion by 2030, achieving a compound annual growth rate (CAGR) of 3.8%. This anticipated growth throughout the forecast period stems from progress in fertility drug formulations, the development of personalized fertility treatments, the wider adoption of AI-driven fertility tracking, the expansion of fertility tourism, and growing investments in reproductive health. Significant trends expected in this period encompass an escalating demand for assisted reproductive treatments, an increased emphasis on hormonal and ovulation therapies, the advancing utilization of sophisticated diagnostic techniques, the proliferation of fertility clinics and services, and the integration of digital platforms into fertility care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20787&type=smp

Which Economic Or Industry Drivers Are Impacting The Female Infertility Market?

The growing occurrence of infertility is projected to fuel the expansion of the female infertility market in the coming period. Infertility is defined as the inability to conceive after 12 months of consistent, unprotected sexual intercourse. This rise in infertility is influenced by factors such as delayed childbearing, evolving lifestyle habits, exposure to environmental toxins, increasing rates of obesity, and heightened stress levels. Female infertility treatment is essential for addressing and managing foundational medical, hormonal, or structural issues that impede fertility, thus improving the likelihood of conception and preventing irreversible infertility. As an illustration, in April 2023, the World Health Organization, a Switzerland-based intergovernmental organization, reported that around 17.5% of the global adult population, equating to about 1 in 6 individuals, contend with infertility. Therefore, the rising prevalence of infertility serves as a significant impetus for the growth of the female infertility market.

How Is The Female Infertility Market Divided Into Its Major Segments?

The female infertility market covered in this report is segmented –

1) By Treatment: Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Clomiphene Citrate: Oral Clomiphene Citrate, Injectable Clomiphene Citrate

2) By Gonadotropins: Recombinant Gonadotropins, Urinary Gonadotropins, Human Chorionic Gonadotropin (hCG)

3) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

4) By Letrozole: Oral Letrozole Tablets, Injectable Letrozole

5) By Bromocriptine: Oral Bromocriptine Tablets, Intranasal Bromocriptine

Which Trends Are Impacting The Growth Of The Female Infertility Market?

Leading companies within the female infertility market are concentrating on developing innovative products, such as non-invasive diagnostic tests, to gain a competitive advantage in the industry. A non-invasive diagnostic test is a medical procedure that identifies conditions or diseases without requiring surgical intervention or penetration of the body. For instance, in August 2024, Heranova Lifesciences, a US-based biotech firm, initiated an early access program for HerResolve, a non-invasive diagnostic test specifically for endometriosis. Endometriosis affects around 200 million women globally, causing symptoms including infertility, pain, and bleeding. For many women, obtaining an accurate diagnosis takes an average of 7-10 years from the onset of symptoms, mainly because of diverse symptom presentations and the invasive nature of the most reliable diagnostic method, exploratory laparoscopic surgery. HerResolve has the potential to shorten this diagnostic delay from years to mere months, thereby improving patient and healthcare outcomes by significantly reducing the timeline.

Who Are The Prominent Organizations Shaping The Female Infertility Market?

Major companies operating in the female infertility market are Pfizer Inc, Merck And Co Inc, Mayo Clinic, Teva Pharmaceutical Industries Ltd, Organon Theramex, Juniper Reproductive Health Ltd, Ferring Pharmaceuticals, Mankind Pharma, ARMC IVF, Zydus Cadila Healthcare, IBSA Institut Biochimique, Oxolife, Ava AG, Merck KGaA, Gedeon Richter Plc, Novartis AG, AbbVie Inc, Ipsen, Theramex, Vitrolife AB, Conceivable Life Sciences, AIVF

Read the full female infertility market report here:

https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report

What Are The Top-Performing Regions Within The Female Infertility Market?

Europe was the largest region in the female infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the female infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Female Infertility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20787&type=smp

Browse Through More Reports Similar to the Global Female Infertility Market 2026, By The Business Research Company

Male Fertility Global Market Report

https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report

Fertility Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Treatments Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795